263 related articles for article (PubMed ID: 38231407)
1. Mixed Aspergillosis and Mucormycosis Infections in Patients with COVID-19: Case Series and Literature Review.
Sasani E; Pakdel F; Khodavaisy S; Salehi M; Salami A; Sohrabi M; Aminishakiba P; Amirafzali I; Salami Khaneshan A
Mycopathologia; 2024 Jan; 189(1):10. PubMed ID: 38231407
[TBL] [Abstract][Full Text] [Related]
2. Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital.
Paul M; Sasidharan J; Taneja J; Chatterjee K; Abbas SZ; Chowdhury V; Das A
Med Mycol J; 2022; 63(3):59-64. PubMed ID: 36047183
[TBL] [Abstract][Full Text] [Related]
3. COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.
Benhadid-Brahmi Y; Hamane S; Soyer B; Mebazaa A; Alanio A; Chousterman B; Bretagne S; Dellière S
J Mycol Med; 2022 Mar; 32(1):101231. PubMed ID: 34864498
[TBL] [Abstract][Full Text] [Related]
4. Aspergillosis and Mucormycosis in COVID-19 Patients: A Systematic Review.
Afzal S; Nasir M
J Coll Physicians Surg Pak; 2022 May; 32(5):639-645. PubMed ID: 35546702
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of co-existent COVID-19-associated pulmonary aspergillosis (CAPA) and its impact on early mortality in patients with COVID-19-associated pulmonary mucormycosis (CAPM).
Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur V; Maturu VN; Srinivasan A; Sethuraman N; Sibia RPS; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Sehgal IS; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Gandra RR; Sistla SK; Padaki PA; Ramar D; Panigrahi MK; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
Mycoses; 2024 May; 67(5):e13745. PubMed ID: 38767273
[TBL] [Abstract][Full Text] [Related]
6. COVID-19-associated mucormycosis - "The Black fungus" with associated invasive aspergillosis and actinomycosis infection: Series of 5 cases in the Indian scenario.
Menia R; Raychaudhuri S; Agarwal C; Taneja J
Indian J Pathol Microbiol; 2023; 66(4):823-828. PubMed ID: 38084540
[TBL] [Abstract][Full Text] [Related]
7. Isolated cerebral Mucormycosis and Aspergillosis coinfection in an immunocompromised adult.
Sun G; Weiss A; Zhao J; Silver M; DeMaio M; Dehbashi S
BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37640409
[TBL] [Abstract][Full Text] [Related]
8. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study.
Avatef Fazeli M; Rezaei L; Javadirad E; Iranfar K; Khosravi A; Amini Saman J; Poursabbagh P; Ghadami MR; Parandin MM; Dehghani A; Ahmadi Jouybari T; Mahdavian B; Eivazi N; Rezaei S; Rezaei A; Emami B; Haqgou M; Bozorgomid A; Sayad B
Mycoses; 2021 Nov; 64(11):1366-1377. PubMed ID: 34252988
[TBL] [Abstract][Full Text] [Related]
9. Oral mucormycosis associated with COVID-19 and diabetes mellitus: Case report and literature review.
Velasco JC; Vargas LJ; García L; Torres IJ; González IC
Biomedica; 2024 Mar; 44(1):10-15. PubMed ID: 38648346
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and mucormycosis superinfection: the perfect storm.
Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
[TBL] [Abstract][Full Text] [Related]
11. COVID-19-associated mucormycosis: a systematic review and meta-analysis of 958 cases.
Özbek L; Topçu U; Manay M; Esen BH; Bektas SN; Aydın S; Özdemir B; Khostelidi SN; Klimko N; Cornely O; Zakhour J; Kanj SS; Seidel D; Hoenigl M; Ergönül Ö
Clin Microbiol Infect; 2023 Jun; 29(6):722-731. PubMed ID: 36921716
[TBL] [Abstract][Full Text] [Related]
12. Maxillary mucormycosis and aspergillosis in post-COVID-19 patients in Mexico: A case series.
Urias-Barreras CM; Rodríguez-Archilla A; Canizalez-Roman A; Bastidas DA; León-Sicairos NM
J Stomatol Oral Maxillofac Surg; 2024 Feb; 125(1):101615. PubMed ID: 37648209
[TBL] [Abstract][Full Text] [Related]
13. Risk factors, mortality, and predictors of survival in COVID-19-associated pulmonary mucormycosis: a multicentre retrospective study from India.
Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur V; Maturu VN; Srinivasan A; Sethuraman N; Singh Sibia RP; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Sehgal IS; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Gandra RR; Sistla SK; Padaki PA; Ramar D; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
Clin Microbiol Infect; 2024 Mar; 30(3):368-374. PubMed ID: 38081413
[TBL] [Abstract][Full Text] [Related]
14. Pediatric mucormycosis associated with COVID-19: A systematic review of clinical cases.
Amaral LB; Carlesse F; Rossato L
Enferm Infecc Microbiol Clin (Engl Ed); 2024; 42(6):321-326. PubMed ID: 38216422
[TBL] [Abstract][Full Text] [Related]
15. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
[TBL] [Abstract][Full Text] [Related]
16. [Mucormycosis in the time of COVID-19: risks and challenges].
Seidel D; Sal E; Nacov JA; Cornely OA; Kurzai O
Dtsch Med Wochenschr; 2024 May; 149(10):569-578. PubMed ID: 38657596
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y;
Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus and other underlying conditions in patients with coronavirus disease 2019 associated rhino-orbito-cerebral mucormycosis: a systematic review and meta-analysis.
Zobairy H; Salem MM; Ghajarzadeh M; Mirmosayyeb O; Mirsalehi M
J Laryngol Otol; 2022 Sep; 136(9):788-798. PubMed ID: 35514092
[TBL] [Abstract][Full Text] [Related]
19. COVID-19-associated mucormycosis: An updated systematic review of literature.
Pal R; Singh B; Bhadada SK; Banerjee M; Bhogal RS; Hage N; Kumar A
Mycoses; 2021 Dec; 64(12):1452-1459. PubMed ID: 34133798
[TBL] [Abstract][Full Text] [Related]
20. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
